Life Sciences

Boston Scientific settles patent dispute

Device Regulation Alert: Safety, Compliance and Reimbursement News, March 30, 2009

Boston Scientific will take a $50 million pre-tax charge to its earnings to settle all outstanding lawsuits with Bruce N. Saffran, MD, PhD, according to a March 16 regulatory filing with the SEC.

Saffran sued Boston Scientific in 2005, alleging some of the company’s coronary stent systems infringed on his patent.

Read more about Boston Scientific's settlement with Saffran.